12Suppliers
21Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Pacific Biosciences of California, Inc. (PACB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

37Total relationships
2Distinct source URLs
7High confidence
0.722Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Pacific Biosciences of California, Inc. Suppliers

TickerNameConfidenceEvidence
INSTRUMENTS INSTRUMENTS 90% We have chosen to source certain products and critical components from a single source, including suppliers for our SMRT Cells, reagents, and instruments.
REAGENTS REAGENTS 90% We have chosen to source certain products and critical components from a single source, including suppliers for our SMRT Cells, reagents, and instruments.
SMRT-CELLS SMRT-CELLS 90% We have chosen to source certain products and critical components from a single source, including suppliers for our SMRT Cells, reagents, and instruments.
BNGO Bionano Genomics, Inc. 72% We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design…
BNGO Bionano Genomics, Inc. 72% Reciprocal relationship from BNGO graph: Reciprocal relationship from PACB graph: Reciprocal relationship from BNGO graph: Reciprocal relationship from PACB graph: We manufacture sequencing instrumen…
GH Guardant Health, Inc. 72% Reciprocal relationship from GH graph: Reciprocal relationship from PACB graph: Reciprocal relationship from GH graph: Reciprocal relationship from PACB graph: Reciprocal relationship from GH graph: …
QGEN Qiagen N.V. 72% We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design…
QGEN Qiagen N.V. 72% Reciprocal relationship from QGEN graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo …
TMO Thermo Fisher Scientific Inc. 72% We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from PACB graph: Reciprocal relationship from TMO graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments…
TXG 10x Genomics, Inc. 72% Reciprocal relationship from TXG graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo P…
TXG 10x Genomics, Inc. 72% We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design…

Pacific Biosciences of California, Inc. Customers

TickerNameConfidenceEvidence
BNGO Bionano Genomics, Inc. 72% Reciprocal relationship from BNGO graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo …
BNGO Bionano Genomics, Inc. 72% We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design…
GH Guardant Health, Inc. 72% Reciprocal relationship from GH graph: r therapy selection, that sell molecular diagnostic tests for cancer to physicians and have or may develop tests that compete with our tests. In addition, we ar…
QGEN Qiagen N.V. 72% We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design…
QGEN Qiagen N.V. 72% Reciprocal relationship from QGEN graph: Reciprocal relationship from PACB graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from PACB graph: We manufacture sequencing instrumen…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo P…
TMO Thermo Fisher Scientific Inc. 72% We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design…
TXG 10x Genomics, Inc. 72% Reciprocal relationship from TXG graph: Reciprocal relationship from PACB graph: Reciprocal relationship from TXG graph: Reciprocal relationship from PACB graph: Reciprocal relationship from TXG grap…
TXG 10x Genomics, Inc. 72% We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design…
CAPITAL-RESOURCES CAPITAL-RESOURCES 62% n Form 10-K, pursuant to Instruction 2 to paragraph (b) of Item 303 of Regulation S-K. Our MD&A is organized into the following sections: • Overview and Outlook • Results of Operations • Liquidity an…
COMPANY-ILLUMINA-CAMBRIDGE-LIMITED COMPANY-ILLUMINA-CAMBRIDGE-LIMITED 62% tal, social or governance responsibilities may result in additional costs and risks, and may adversely impact our reputation, employee retention, and willingness of customers and suppliers to do busi…
COMPLETE-GENOMICS-THERMO-ONT-LTD COMPLETE-GENOMICS-THERMO-ONT-LTD 62% materially and adversely impact our business. We operate in a highly competitive industry and if we are not able to compete effectively, our business and operating results will likely be harmed. Ther…
DELAWARE-GENERAL-CORPORATION DELAWARE-GENERAL-CORPORATION 62% or if we are unable to alter our processes or sources of supply to avoid using such materials. In such circumstances, the reputational harm could materially and adversely affect our business, financi…
EXHIBITS-INCORPORATED EXHIBITS-INCORPORATED 62% tal, social or governance responsibilities may result in additional costs and risks, and may adversely impact our reputation, employee retention, and willingness of customers and suppliers to do busi…
ILLUMINA-CAMBRIDGE-LIMITED ILLUMINA-CAMBRIDGE-LIMITED 62% llion in instrument revenue, $21.8 million in consumables revenue and $5.6 million in service and other revenue during the three months ended March 31, 2026. Revenue was comprised of $11.0 million in…
ILMN Illumina, Inc. 62% Reciprocal relationship from ILMN graph: Reciprocal relationship from PACB graph: tal, social or governance responsibilities may result in additional costs and risks, and may adversely impact our rep…
MANNHEIM-GERMANY-ONT-LTD MANNHEIM-GERMANY-ONT-LTD 62% strict of Delaware and, previously, with the U.S. International Trade Commission, in the High Court of England and Wales and in the District Court of Mannheim, Germany. ONT Ltd. previously filed clai…
METRICHOR-LTD METRICHOR-LTD 62% • general economic, industry and market conditions; • the impact of catastrophic events, including health epidemics or pandemics and military or other armed conflicts; • the regulatory environment in…
ONT-LTD ONT-LTD 62% tially competing technologies, products and/or services, including ONT Ltd. and its subsidiaries, against whom we have filed complaints for patent infringement in the U.S. District Court for the Dist…
ONT-LTD-OXFORD-NANOPORE-TECHNOLOGIES-INC ONT-LTD-OXFORD-NANOPORE-TECHNOLOGIES-INC 62% • general economic, industry and market conditions; • the impact of catastrophic events, including health epidemics or pandemics and military or other armed conflicts; • the regulatory environment in…
U-S-BANK-TRUST-COMPANY U-S-BANK-TRUST-COMPANY 62% e). On the 361 st day after such event of default (if the event of default relating to our failure to comply with its obligations is not cured or waived prior to such 361 st day), the 2029 Notes shal…

Pacific Biosciences of California, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PACB-DEBT-11647 Warrants outstanding: 4200000 90% xbrl warrant detail from xbrl 2016-12-31.
PACB-DEBT-11648 Xbrl Convertible 90% xbrl convertible detail from xbrl 2026-03-31.
PACB-DEBT Debt stack $13.5M 90% Market cache reports total debt of $13.5M.

Pacific Biosciences of California, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Pacific Biosciences of California, Inc..

Pacific Biosciences of California, Inc. Ownership

HolderNameConfidenceEvidence
PACB-OWNER-ARK-INVESTMENT-MANAGEMENT-LLC ARK Investment Management LLC 90% 13F overlay lists ARK Investment Management LLC as top holder; 235 tracked holders.

Pacific Biosciences of California, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ILMN Illumina, Inc. 100.00 1 ['customer']
GRAL GRAIL, Inc. 100.00 2
TMO Thermo Fisher Scientific Inc. 100.00 2 ['customer', 'supplier']
MYGN Myriad Genetics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
EXAS Exact Sciences Corp 100.00 2
BNGO Bionano Genomics, Inc. 100.00 1 ['customer', 'supplier']
YDES YD Bio Ltd 100.00 2
QGEN Qiagen N.V. 100.00 1 ['customer', 'supplier']
TXG 10x Genomics, Inc. 100.00 1 ['customer', 'supplier']
TEM Tempus AI, Inc. 100.00 2
VRAX Virax Biolabs Group Limited 50.00 2
BIO Bio-Rad Laboratories, Inc. 50.00 2
FLGT Fulgent Genetics, Inc. 50.00 2
SOPH SOPHiA GENETICS SA 50.00 2
IDXG Interpace Biosciences, Inc. 50.00 2
MANU Manchester 50.00 2
LDTCF LeddarTech Holdings Inc. 50.00 2
STQN Strategic Acquisitions, Inc. 50.00 2
SAPGF SAP SE 50.00 2
🔐
PACB
Unlock PACB Supply Chain Data
Verified relationships include:
INSTRUMENTSINSTRUMENTSSupplier90%
REAGENTSREAGENTSSupplier90%
BNGOBionano Genomics, Inc.Customer72%
BNGOBionano Genomics, Inc.Customer72%
+33 more relationships locked
Subscribe — View plans →